The Journal of Pediatrics
Volume 151, Issue 6 , Pages 653-658 , December 2007

Glucose Tolerance, Insulin Secretion, and Insulin Sensitivity in Children and Adolescents with Cystic Fibrosis and No Prior History of Diabetes

  • Deborah A. Elder, MD

      Affiliations

    • Division of Endocrinology, Cincinnati Children’s Hospital, Department of Pediatrics, Cincinnati, Ohio
    • Corresponding Author InformationReprint requests: Deborah A. Elder, MD, Cincinnati Children’s Hospital Medical Center, Division of Endocrinology, MLC 7012, 3333 Burnet Ave, Cincinnati, OH 45229-3039.
    • ,
  • Jamie L. Wooldridge, MD

      Affiliations

    • Division of Pulmonary Medicine, Cincinnati Children’s Hospital, Department of Pediatrics, Cincinnati, Ohio
    • ,
  • Lawrence M. Dolan, MD

      Affiliations

    • Division of Endocrinology, Cincinnati Children’s Hospital, Department of Pediatrics, Cincinnati, Ohio
    • ,
  • David A. D’Alessio, MD

      Affiliations

    • Division of Endocrinology, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio.

Received 4 December 2006 ,Revised 12 March 2007 ,Accepted 2 May 2007.

References 

  1. Costa M, Potvin S, Berthiaume Y, Gauthier L, Jeanneret A, Lavoie A, et al. Diabetes: a major co-morbidity of cystic fibrosis. Diabetes Metab. 2005;31:221–232
  2. Cawood TJ, McKenna MJ, Gallagher CG, Smith D, Chung WY, Gibney J, et al. Cystic fibrosis-related diabetes in adults. Ir Med J. 2006;99:83–86
  3. Milla CE, Billings J, Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care. 2005;28:2141–2144
  4. Arrigo T, Cucinotta D, Conti Nibali S, Di Cesare E, Di Benedetto A, Magazzu G, et al. Longitudinal evaluation of glucose tolerance and insulin secretion in non-diabetic children and adolescents with cystic fibrosis: results of a two-year follow-up. Acta Paediatr. 1993;82:249–253
  5. Iannucci A, Mukai K, Johnson D, Burke B. Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum Pathol. 1984;15:278–284
  6. Lohr M, Goertchen P, Nizze H, Gould NS, Gould VE, Oberholzer M, et al. Cystic fibrosis associated islet changes may provide a basis for diabetes (An immunocytochemical and morphometrical study). Virchows Arch A Pathol Anat Histopathol. 1989;414:179–185
  7. Mackie AD, Thornton SJ, Edenborough FP. Cystic fibrosis-related diabetes. Diabet Med. 2003;20:425–436
  8. Moran A, Doherty L, Wang X, Thomas W. Abnormal glucose metabolism in cystic fibrosis. J Pediatr. 1998;133:10–17
  9. Hardin DS, LeBlanc A, Lukenbough S, Seilheimer DK. Insulin resistance is associated with decreased clinical status in cystic fibrosis. J Pediatr. 1997;130:948–956
  10. Holl RW, Wolf A, Thon A, Bernhard M, Buck C, Missel M, et al. Insulin resistance with altered secretory kinetics and reduced proinsulin in cystic fibrosis patients. J Pediatr Gastroenterol Nutr. 1997;25:188–193
  11. Austin A, Kalhan SC, Orenstein D, Nixon P, Arslanian S. Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis. J Clin Endocrinol Metab. 1994;79:80–85
  12. Hardin DS, Leblanc A, Marshall G, Seilheimer DK. Mechanisms of insulin resistance in cystic fibrosis. Am J Physiol Endocrinol Metab. 2001;281:E1022–E1028
  13. Moran A, Pyzdrowski KL, Weinreb J, Kahn BB, Smith SA, Adams KS, et al. Insulin sensitivity in cystic fibrosis. Diabetes. 1994;43:1020–1026
  14. Lanng S, Thorsteinsson B, Roder ME, Nerup J, Koch C. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clin Endocrinol (Oxf). 1994;41:217–223
  15. Yung B, Noormohamed FH, Kemp M, Hooper J, Lant AF, Hodson ME. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction. Diabet Med. 2002;19:221–226
  16. Holl RW, Heinze E, Wolf A, Rank M, Teller WM. Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis. Eur J Pediatr. 1995;154:356–361
  17. Tofe S, Moreno JC, Maiz L, Alonso M, Escobar H, Barrio R. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis. Eur J Endocrinol. 2005;152:241–247
  18. Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med. 2000;162:891–895
  19. Lanng S, Thorsteinsson B, Nerup J, Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr. 1992;151:684–687
  20. Dobson L, Hattersley AT, Tiley S, Elworthy S, Oades PJ, Sheldon CD. Clinical improvement in cystic fibrosis with early insulin treatment. Arch Dis Child. 2002;87:430–431
  21. Elder DA, Prigeon RL, Wadwa RP, Dolan LM, D’Alessio DA. Beta-cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adults. J Clin Endocrinol Metab. 2006;91:185–191
  22. Phillips DI, Clark PM, Hales CN, Osmond C. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med. 1994;11:286–292
  23. Wareham NJ, Phillips DI, Byrne CD, Hales CN. The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med. 1995;12:931
  24. Moran A, Hardin D, Rodman D, Allen HF, Beall RJ, Borowitz D, et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract. 1999;45:61–73
  25. Position statements & ADA statements. Diabetes Care. 2007;30(Suppl 1):93–95
  26. Dobson L, Sheldon CD, Hattersley AT. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet Med. 2004;21:691–696
  27. Cutfield WS, Hofman PL. Simple fasting methods to assess insulin sensitivity in childhood. Horm Res. 2005;64(Suppl 3):25–31
  28. Ahmad T, Nelson R, Taylor R. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis. Metabolism. 1994;43:163–167
  29. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects (Evidence for a hyperbolic function). Diabetes. 1993;42:1663–1672
  30. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA. beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab. 2005;90:493–500
  31. Solomon MP, Wilson DC, Corey M, Kalnins D, Zielenski J, Tsui LC, et al. Glucose intolerance in children with cystic fibrosis. J Pediatr. 2003;142:128–132
  32. Garagorri JM, Rodriguez G, Ros L, Sanchez A. Early detection of impaired glucose tolerance in patients with cystic fibrosis and predisposition factors. J Pediatr Endocrinol Metab. 2001;14:53–60
  33. Lombardo F, De Luca F, Rosano M, Sferlazzas C, Lucanto C, Arrigo T, et al. Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia. Eur J Endocrinol. 2003;149:53–59
  34. Mueller-Brandes C, Holl RW, Nastoll M, Ballmann M. New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis. Eur Respir J. 2005;25:715–717
  35. Moran A. Cystic fibrosis-related diabetes: an approach to diagnosis and management. Pediatr Diabetes. 2000;1:41–48

 Supported by NIH Grants M01 RR08084 and DK 57900.

PII: S0022-3476(07)00461-1

doi: 10.1016/j.jpeds.2007.05.012

The Journal of Pediatrics
Volume 151, Issue 6 , Pages 653-658 , December 2007

Article Tools

* Image Usage & Resolution